XML 67 R50.htm IDEA: XBRL DOCUMENT v3.19.3
Fair value measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2019
Dec. 31, 2018
Jun. 30, 2018
Dec. 31, 2017
Derivative Financial Instruments, Liabilities [Member] | Level 3                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Balance - Beginning of Period, Liabilities   $ 2   $ 2        
Transfers into level 3, liability   0   0        
Transfers out of Level 3, Liabilities   0   0        
Change in Net Unrealized Gains (Losses) included in OCI, Liabilities   0   0        
Net Realized Gains/Losses, Liabilities   0   0        
Purchases, Liabilities   0   0        
Sales, Liabilities   0   0        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements   0   0        
Balance - End of Period, Liabilities   2   2        
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)   0   0        
Guaranteed Minimum Income Benefit [Member]                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Guaranteed Benefit Liability, Net $ 935 453 $ 935 453 $ 815 $ 861 $ 497 $ 550
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Balance - Beginning of Period, Liabilities 403 125 452 204        
Balance - End of Period, Liabilities 509 71 509 71        
Guaranteed Minimum Income Benefit [Member] | Guarantees [Member] | Level 3                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Balance - Beginning of Period, Liabilities 403 [1] 125 [2] 452 [3] 204 [4]        
Transfers into level 3, liability 0 0 0 0        
Transfers out of Level 3, Liabilities 0 0 0 0        
Change in Net Unrealized Gains (Losses) included in OCI, Liabilities 0 0 0 0        
Net Realized Gains/Losses, Liabilities 106 (54) 57 (133)        
Purchases, Liabilities 0 0 0 0        
Sales, Liabilities 0 0 0 0        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 0 0 0 0        
Balance - End of Period, Liabilities 509 [1],[3] 71 [2],[4] 509 [1],[3] 71 [2],[4]        
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) $ 106 $ (54) $ 57 $ (133)        
[1] Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $935 million at September 30, 2019, and $815 million at June 30, 2019, which includes a fair value derivative adjustment of $509 million and $403 million, respectively
[2]
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $453 million at September 30, 2018, and $497 million at June 30, 2018, which includes a fair value derivative adjustment of $71 million and $125 million, respectively.
[3]
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $935 million at September 30, 2019, and $861 million at December 31, 2018, which includes a fair value derivative adjustment of $509 million and $452 million, respectively.
[4]
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $453 million at September 30, 2018, and $550 million at December 31, 2017, which includes a fair value derivative adjustment of $71 million and $204 million, respectively.